These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7294555)

  • 21. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of pulmonary artery banding in the setting of ventricular septal defects and severely elevated pulmonary vascular resistance.
    Khan SA; Gelb BD; Nguyen KH
    Congenit Heart Dis; 2006 Sep; 1(5):244-50. PubMed ID: 18377533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of the preparation CIBA 31 531-Ba on respiration and pulmonary circulation].
    Jedlicka K; Daum S; Nikodýmová L; Stiksa J
    Cas Lek Cesk; 1969 May; 108(21):629-33. PubMed ID: 5788079
    [No Abstract]   [Full Text] [Related]  

  • 24. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
    Ricksten S
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Vasodilators and Anesthesia Considerations.
    Green JB; Hart B; Cornett EM; Kaye AD; Salehi A; Fox CJ
    Anesthesiol Clin; 2017 Jun; 35(2):221-232. PubMed ID: 28526144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension.
    Eysmann SB; Palevsky HI; Reichek N; Hackney K; Douglas PS
    Chest; 1991 May; 99(5):1066-71. PubMed ID: 2019158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilators in pulmonary hypertension.
    Peacock A
    Thorax; 1993 Dec; 48(12):1196-9. PubMed ID: 8303622
    [No Abstract]   [Full Text] [Related]  

  • 29. The management of primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    JAMA; 1991 Feb; 265(8):1014-20. PubMed ID: 1992195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular size is acutely decreased by inhaled nitric oxide in newborns with pulmonary hypertension.
    Day RW
    Am J Perinatol; 1998 Jul; 15(7):445-51. PubMed ID: 9759913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.
    Nilsson KF; Gustafsson LE
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00462. PubMed ID: 30693089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of primary pulmonary hypertension.
    Uren NG; Oakley CM
    Br Heart J; 1991 Aug; 66(2):119-21. PubMed ID: 1883661
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary hypertension, right ventricular failure, and vasodilator therapy. Making pathophysiologic sense.
    Davila F
    Chest; 1986 Sep; 90(3):467-8. PubMed ID: 3743174
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
    J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
    [No Abstract]   [Full Text] [Related]  

  • 36. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anesthetic management of children with pulmonary arterial hypertension.
    Galante D; Meola S; Pellico G; Tancredi ML; Milillo R
    Paediatr Anaesth; 2008 Jun; 18(6):562-3; author reply 563-4. PubMed ID: 18445205
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasodilatory treatment of pulmonary hypertension.
    Widimský J
    Eur J Respir Dis; 1986 Mar; 68(3):161-6. PubMed ID: 2870937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case for treatment of selected patients with primary pulmonary hypertension.
    Reeves JT; Groves BM; Turkevich D
    Am Rev Respir Dis; 1986 Aug; 134(2):342-6. PubMed ID: 3740659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension.
    Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR
    Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.